OVERVIEW

3rd EACR Conference on Cancer Genomics is organized by European Association for Cancer Research and would be held during Jun 25 - 28, 2017 at Churchill College, Cambridge, England, United Kingdom.

Cancer Genomics 2017 will be relevant to participants from across a number of fields including cancer medicine, cancer biology, translational research, bioinformatics, epigenomics, cancer immunology and molecular pathology. Importantly, early career researchers will have the opportunity to present their work to the international community.

Cancer Genomics 2017 is the third EACR conference on this topic, and it has now established itself as the premier European conference dedicated to cancer genomics. In 2017 it will update you on the latest exciting developments: cancers as communities of clones and communities of cells, liquid biopsies, genomics and cancer immunology.

Topics :

• Immunology in the age of single cell genomics
• Onco-microbiota
• Towards deciphering the functional genetic and neo antigenic landscape in cancer
• T cell recognition of human cancer
• Exploiting acquired vulnerabilities of drug resistant tumours
• Precision medicine
• Clonal and cellular heterogeneity landscapes of cancer
• Role of rare mutations in the onset of cancer
• Tumour genomes shed light into mutational processes and cancer vulnerabilities
• Molecular analysis of circulating tumour cells
• Inferring expressed genes by whole-genome sequencing of plasma DNA
• Predicting relapse using circulating tumour DNA
• Patient-derived primary cancer cells, integrative omics and functional drug testing
• Tracking cancer evolution.

KEY DATES

Event Start Date
25 Jun, 2017
Event Start Date
Event End Date
28 Jun, 2017
Event End Date

SPECIALITIES

OncologyGenetics

SUGGESTED HOTELS

CONFERENCE VENUE

LocationChurchill College
Storeys Way

RELATED CONFERENCES & LIVE WEBINARS

Feb 01 - 02, 2027 | Dubai, Dubai, UAE

Oncology
30 CME
...
More actions
GB£19

Feb 01 - 02, 2027 | Dubai, Dubai, UAE

Pathology
30 CME
...
More actions
GB£45

Oct 29 - 30, 2026 | Orlando, Florida, USA

Oncology
More actions
US$235